Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 130

    1.

    Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.

    Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM.

    Ann Intern Med. 2008 Nov 4;149(9):659-69. Epub 2008 Oct 6.PMID: 18838717 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

    Whitlock EP, Lin JS, Liles E, Beil TL, Fu R.

    Ann Intern Med. 2008 Nov 4;149(9):638-58. Epub 2008 Oct 6. Review.PMID: 18838718 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost-effectiveness of colonoscopy in screening for colorectal cancer.

    Sonnenberg A, Delcò F, Inadomi JM.

    Ann Intern Med. 2000 Oct 17;133(8):573-84.PMID: 11033584 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost-effectiveness of screening for colorectal cancer in the general population.

    Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

    JAMA. 2000 Oct 18;284(15):1954-61.PMID: 11035892 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

    Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Habbema JD, Kuipers EJ.

    J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22. Epub 2009 Sep 24.PMID: 19779203 [PubMed - indexed for MEDLINE]Related articles

    6.

    Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

    Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.

    Ann Intern Med. 2001 Nov 6;135(9):769-81.PMID: 11694102 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Nov 4;149(9):627-37. Epub 2008 Oct 6.PMID: 18838716 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Colorectal cancer test use--Maryland, 2002-2006.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 2007 Sep 14;56(36):932-6.PMID: 17851446 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.

    O'Leary BA, Olynyk JK, Neville AM, Platell CF.

    J Gastroenterol Hepatol. 2004 Jan;19(1):38-47.PMID: 14675241 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

    Song K, Fendrick AM, Ladabaum U.

    Gastroenterology. 2004 May;126(5):1270-9.PMID: 15131787 [PubMed - indexed for MEDLINE]Related articles

    11.

    Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

    Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

    J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.PMID: 17895475 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.

    Daniels K, McKee M.

    J R Army Med Corps. 1995 Oct;141(3):142-50. Erratum in: J R Army Med Corps 1996 Feb;142(1):49. PMID: 8568748 [PubMed - indexed for MEDLINE]Related articles

    13.

    Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

    Vijan S, Hwang EW, Hofer TP, Hayward RA.

    Am J Med. 2001 Dec 1;111(8):593-601.PMID: 11755501 [PubMed - indexed for MEDLINE]Related articles

    14.

    Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 2003 Mar 14;52(10):193-6.PMID: 12653456 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.

    Lewis JD, Brown A, Localio AR, Schwartz JS.

    Ann Intern Med. 2002 Jan 15;136(2):99-110.PMID: 11790061 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The impact of colorectal cancer screening on life expectancy.

    Inadomi JM, Sonnenberg A.

    Gastrointest Endosc. 2000 May;51(5):517-23.PMID: 10805834 [PubMed - indexed for MEDLINE]Related articles

    17.

    Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

    Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN.

    Ann Intern Med. 2002 Jul 16;137(2):132-41. Review.PMID: 12118972 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

    Tsoi KK, Ng SS, Leung MC, Sung JJ.

    Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63.PMID: 18638075 [PubMed - indexed for MEDLINE]Related articles

    19.

    Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.

    Rodríguez-Moranta F, Trapero-Bertran M, Castells A, Mas-Canal X, Balaguer F, Pellisé M, Gonzalo V, Ocaña T, Trilla A, Piqué JM.

    Gastroenterol Hepatol. 2008 Aug-Sep;31(7):405-12.PMID: 18783684 [PubMed - indexed for MEDLINE]Related articles

    20.

    Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

    Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy.

    J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.PMID: 15741571 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data